HCMWX
Price
$19.09
Change
+$0.07 (+0.37%)
Updated
Jan 17 closing price
Net Assets
1.71B
RWIBX
Price
$63.81
Change
+$0.46 (+0.73%)
Updated
Jan 17 closing price
Net Assets
126.7B
Ad is loading...

HCMWX vs RWIBX

Header iconHCMWX vs RWIBX Comparison
Open Charts HCMWX vs RWIBXBanner chart's image
HCM Dividend Sector Plus A1
Price$19.09
Change+$0.07 (+0.37%)
VolumeN/A
Net Assets1.71B
American Funds Capital World Gr&Inc R2
Price$63.81
Change+$0.46 (+0.73%)
VolumeN/A
Net Assets126.7B
HCMWX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCMWX vs. RWIBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMWX is a Hold and RWIBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 127B vs. HCMWX (1.71B). RWIBX pays higher dividends than HCMWX: RWIBX (1.05) vs HCMWX (0.00). HCMWX was incepted earlier than RWIBX: HCMWX (10 years) vs RWIBX (23 years). HCMWX is a more actively managed with annual turnover of: 178.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HCMWX: RWIBX (250) vs HCMWX (2500). RWIBX (10.02) and HCMWX (9.59) have marching annual gain over last year. HCMWX return over 5 years is better than : 46.73 vs. RWIBX (24.76).
HCMWXRWIBXHCMWX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD0.3152.01416%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B127B1%
Annual Yield % from dividends0.001.05-
Returns for 1 year9.5910.0296%
Returns for 3 years-9.106.90-132%
Returns for 5 years46.7324.76189%
Returns for 10 yearsN/A44.15-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MXCT4.940.19
+4.00%
MaxCyte
VIRT37.260.33
+0.89%
Virtu Financial
KGC10.310.08
+0.78%
Kinross Gold Corp
IPSC0.91N/A
+0.45%
Century Therapeutics
ABT113.48-0.43
-0.38%
Abbott Laboratories